Alliance Global Partners’ Grand Rounds: A Webinar in Biotech ad Specialty Pharma

Hosted by James Molloy, Managing Director of Equity Research, Biotechnology and Specialty Pharmaceuticals at Alliance Global Partners on Monday, April 26, 2021, at 11:00 Eastern. 
Mr. Kidron, along with Premas Biotech Co-Founder and Managing Director Dr. Prabuddha Kundu, will discuss Oramed Pharmaceuticals’ oral insulin drug, currently in Phase 3 clinical trials, and the oral COVID-19 vaccine candidate of Oravax Medical Inc., which is 63% owned by Oramed Pharmaceuticals.
Investors and the media may register for the live webinar here:

Other upcoming events

Join our mailing list

Skip to content